A detailed history of Ignite Planners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Ignite Planners, LLC holds 34,144 shares of PFE stock, worth $851,551. This represents 0.24% of its overall portfolio holdings.

Number of Shares
34,144
Previous 33,626 1.54%
Holding current value
$851,551
Previous $940,000 5.11%
% of portfolio
0.24%
Previous 0.24%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$27.7 - $31.39 $14,348 - $16,260
518 Added 1.54%
34,144 $988,000
Q2 2024

Jul 12, 2024

BUY
$25.26 - $29.6 $48,246 - $56,536
1,910 Added 6.02%
33,626 $940,000
Q1 2024

Apr 12, 2024

SELL
$25.89 - $29.73 $50,174 - $57,616
-1,938 Reduced 5.76%
31,716 $880,000
Q4 2023

Jan 08, 2024

SELL
$26.13 - $33.94 $120,485 - $156,497
-4,611 Reduced 12.05%
33,654 $968,000
Q3 2023

Oct 10, 2023

BUY
$32.09 - $37.51 $394,450 - $461,072
12,292 Added 47.33%
38,265 $1.27 Million
Q2 2023

Jul 11, 2023

SELL
$36.12 - $41.79 $71,120 - $82,284
-1,969 Reduced 7.05%
25,973 $952,000
Q1 2023

Apr 17, 2023

SELL
$39.39 - $51.28 $75,471 - $98,252
-1,916 Reduced 6.42%
27,942 $1.14 Million
Q4 2022

Feb 02, 2023

BUY
$41.75 - $54.5 $427,478 - $558,025
10,239 Added 52.19%
29,858 $1.53 Million
Q3 2022

Oct 12, 2022

BUY
$43.76 - $53.42 $87,563 - $106,893
2,001 Added 11.36%
19,619 $866,000
Q2 2022

Jul 15, 2022

BUY
$46.53 - $55.17 $8,747 - $10,371
188 Added 1.08%
17,618 $941,000
Q1 2022

May 13, 2022

BUY
$45.75 - $56.69 $39,070 - $48,413
854 Added 5.15%
17,430 $838,000
Q4 2021

Feb 02, 2022

BUY
$41.32 - $61.25 $684,920 - $1.02 Million
16,576 New
16,576 $894,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $140B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ignite Planners, LLC Portfolio

Follow Ignite Planners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ignite Planners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ignite Planners, LLC with notifications on news.